AMAG Pharma (AMAG) Reports Q3 EPS of 6c
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Research and development expenses: 17.12M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development expenses: 17.12M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q3 EPS of $0.06, may not compare the analyst estimate of ($0.08). Revenue for the quarter came in at $25.5 million versus the consensus estimate of $26.3 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
